Cargando…
Glucose Homeostasis, Diabetes Mellitus, and Gender-Affirming Treatment
The transgender (trans) population includes individuals with gender identities more fittingly aligned with the opposite sex or with an alternative that transcends the classical dipole of male/female. Hormonal treatment in transgender individuals aims to suppress the secretion of endogenous sex stero...
Autores principales: | Milionis, Charalampos, Ilias, Ioannis, Venaki, Evangelia, Koukkou, Eftychia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045127/ https://www.ncbi.nlm.nih.gov/pubmed/36979649 http://dx.doi.org/10.3390/biomedicines11030670 |
Ejemplares similares
-
Progesterone in gender-affirming therapy of trans women
por: Milionis, Charalampos, et al.
Publicado: (2022) -
Glycemia after Betamethasone in Pregnant Women without Diabetes—Impact of Marginal Values in the 75-g OGTT
por: Kakoulidis, Ioannis, et al.
Publicado: (2020) -
Alpha-Methyldopa May Attenuate Insulin Demand in Women with Gestational Diabetes Treated with Betamethasone
por: Kakoulidis, Ioannis, et al.
Publicado: (2022) -
Melatonin’s actions are not limited to sleep
por: Venaki, Evangelia, et al.
Publicado: (2023) -
Cystic Fibrosis-Related Diabetes and Subclinical Hypothyroidism in Pregnancy
por: Kakoulidis, Ioannis, et al.
Publicado: (2020)